New drugs that might fly in 2022

Nearly half of the new medicines recommended for approval by the CHMP this month, have either already been green-lighted by the TGA or are currently under review, signalling Australia is catching up to its European counterpart and hinting at what is likely to come early 2022.

To see the whole article please log in.

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

Retype password

Not a member? Sign up here